Abstract | BACKGROUND: METHODS: The human breast cancer cell lines MCF-7 (p53 wildtype) and MDA-MB-231 (p53 mutant) were treated with DCQ under normoxia or hypoxia. Drug toxicity on non-cancerous MCF-10A breast cells was also determined. In vitro cellular responses were investigated by flow cytometry, transfection, western blotting, ELISA and migration assays. The anti-metastatic effect of DCQ was validated in the MDA-MB-231 xenograft mouse model. RESULTS: DCQ selectively induced apoptosis in both human breast cancer cells preferentially under hypoxia without affecting the viability of non-cancerous MCF-10A. Cancer cell death was associated with an increase in reactive oxygen species (ROS) independently of p53 and was inhibited by antioxidants. DCQ-induced ROS was associated with DNA damage, the downregulation of hypoxia inducible factor-1 alpha (HIF-1α), and inhibition of vascular endothelial growth factor ( VEGF) secretion. In MCF-7, HIF-1α inhibition was partially via p53-activation and was accompanied by a decrease in p- mTOR protein, suggesting interference with HIF-1α translation. In MDA-MB-231, DCQ reduced HIF-1α through proteasomal-dependent degradation mechanisms. HIF-1α inhibition by DCQ blocked VEGF secretion and invasion in MCF-7 and led to the inhibition of TWIST in MDA-MB-231. Consistently, DCQ exhibited robust antitumor activity in MDA-MB-231 breast cancer mouse xenografts, enhanced animal survival, and reduced metastatic dissemination to lungs and liver. CONCLUSION:
|
Authors | Khaled Ghattass, Sally El-Sitt, Kazem Zibara, Saide Rayes, Makhluf J Haddadin, Marwan El-Sabban, Hala Gali-Muhtasib |
Journal | Molecular cancer
(Mol Cancer)
Vol. 13
Pg. 12
(Jan 24 2014)
ISSN: 1476-4598 [Electronic] England |
PMID | 24461075
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- HIF1A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Quinoxalines
- RNA, Small Interfering
- quindoxin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Breast Neoplasms
(metabolism, pathology)
- Cell Hypoxia
(physiology)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Enzyme-Linked Immunosorbent Assay
- Female
- Flow Cytometry
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit
(drug effects, metabolism)
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Neoplasm Invasiveness
(pathology)
- Quinoxalines
(pharmacology)
- RNA, Small Interfering
- Signal Transduction
(drug effects)
- Transfection
- Xenograft Model Antitumor Assays
|